rheumatoid arthritis
Exagen Posts Flat to Slight Decline in Preliminary Q4 Report, Gets Conditional NY Approval
The company received conditional approval from New York state for its new systemic lupus erythematosus and rheumatoid arthritis biomarker assays.
Augurex Inks Agreement With Quest Diagnostics to Validate and Sell Rheumatoid Arthritis Test
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.
Australia's Colonial Foundation Commits A$21M for Inflammatory Disease Dx Research Center
The new center will use spatial omics technology and be led by the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (WEHI).
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
Liquid Biopsy Startup Aqtual Raises $16M in Series A Financing
The startup will analyze cell-free DNA to develop blood-based assays to guide treatment in chronic diseases and oncology, starting with rheumatoid arthritis.